Association of the DRD2 gene Taq1A polymorphism and alcoholism:: a meta-analysis of case-control studies and evidence of publication bias

被引:163
|
作者
Munafo, M. R.
Matheson, I. J.
Flint, J.
机构
[1] Univ Bristol, Dept Expt Psychol, Bristol BS8 1TU, Avon, England
[2] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 2JD, England
基金
英国惠康基金;
关键词
DRD2; ANKK1; genetics; alcoholism; meta-analysis; publication bias;
D O I
10.1038/sj.mp.4001938
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We investigated the association of the dopamine D2 receptor ( DRD2) Taq1A polymorphism and alcoholism, using meta- analytic techniques, and specifically undertook an investigation of possible publication bias. Potential publication bias represents a genuine risk to the integrity of published research, but its impact has rarely been documented. We observed a small effect of the DRD2 Taq1A polymorphism on risk of alcoholism, indicating increased alcoholism in individuals possessing the A1 allele of the Taq1A polymorphism ( OR = 1.21, 95% CI 1.13 - 1.30, P < 0.001). This association remained significant when data from samples of European and East Asian ancestry were analyzed separately. We did not find evidence for association in high- severity alcoholism compared to low- severity alcoholism. Removing the first published study significantly reduced the magnitude of the pooled effect size estimate, although the association remained significant. In addition, we observed evidence for possible publication bias and for the strength of individual study effect size to be inversely related to year of publication. These results support the association of the DRD2 Taq1A polymorphism with alcoholism. This conclusion is qualified by the possibility of publication bias in the literature and the observed between- study heterogeneity, which indicates that the observed association may differ in strength between populations or may not exist at all in some populations.
引用
收藏
页码:454 / 461
页数:8
相关论文
共 50 条
  • [21] The effect of ANKK1 Taq1A and DRD2 C957T polymorphisms on executive function: A systematic review and meta-analysis
    Klaus, Kristel
    Butler, Kevin
    Curtis, Ffion
    Bridle, Chris
    Pennington, Kyla
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2019, 100 : 224 - 236
  • [22] Polymorphism of the DRD2/ANKK1 Taq1A gene and depression in open male population of 45-64 years: Epidemiological study
    Gafarov, Valery
    Gromova, Elena
    Panov, Dmitriy
    Gagulin, Igor
    Gafarova, Almira
    BIPOLAR DISORDERS, 2021, 23 : 66 - 66
  • [23] Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism:: Analysis of pooled data from two clinical trials
    David, Sean P.
    Strong, David R.
    Munafo, Marcus R.
    Brown, Richard A.
    Lloyd-Richardson, Elizabeth E.
    Wileyto, Paul E.
    Evins, Eden A.
    Shields, Peter G.
    Lerman, Caryn
    Niaura, Raymond
    NICOTINE & TOBACCO RESEARCH, 2007, 9 (12) : 1251 - 1257
  • [24] Case-control analysis of DRD2 gene polymorphisms in drug addicted patients
    Sznabowicz, Mariusz
    Jasiewicz, Andrzej
    Iskra-Trifunovic, Joanna
    Malecka, Iwona
    Karakiewicz, Beata
    Kotwas, Artur
    Samochowiec, Jerzy
    Grzywacz, Anna
    PSYCHIATRIA POLSKA, 2018, 52 (06) : 1013 - 1022
  • [25] D2 dopamine receptor (DRD2) gene Taq1A polymorphism and the eatingrelated psychological traits in eating disorders (anorexia nervosa and bulimia) and obesity
    E. Nisoli
    A. Brunani
    E. Borgomainerio
    C. Tonello
    L. Dioni
    L. Briscini
    G. Redaelli
    E. Molinari
    F. Cavagnini
    M. O. Carruba
    Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity, 2007, 12 : 91 - 96
  • [26] Prolactin response to nemonapride, a selective antagonist for D2 like dopamine receptors, in schizophrenic patients in relation to Taq1A polymorphism of DRD2 gene
    Mihara, K
    Kondo, T
    Suzuki, A
    Yasui, N
    Nagashima, U
    Ono, S
    Otani, K
    Kaneko, S
    PSYCHOPHARMACOLOGY, 2000, 149 (03) : 246 - 250
  • [27] Association between DRD2/ANKK1 TaqIA polymorphism and common illicit drug dependence: Evidence from a meta-analysis
    Deng, Xiao-Dong
    Jiang, Hai
    Ma, Ying
    Gao, Qin
    Zhang, Bo
    Mu, Bo
    Zhang, Li-Xia
    Zhang, Wei
    Er, Zhe-Er Mu
    Xie, Ying
    Liu, Yun
    HUMAN IMMUNOLOGY, 2015, 76 (01) : 42 - 51
  • [28] Prolactin response to nemonapride, a selective antagonist for D2 like dopamine receptors, in schizophrenic patients in relation to Taq1A polymorphism of DRD2 gene
    K. Mihara
    Tsuyoshi Kondo
    Akihito Suzuki
    Norio Yasui
    Udai Nagashima
    Shingo Ono
    Koichi Otani
    Sunao Kaneko
    Psychopharmacology, 2000, 149 : 246 - 250
  • [29] Association between DRD2/ANKK1 TaqIA Polymorphism and Susceptibility with Tourette Syndrome: A Meta-Analysis
    Yuan, Aihua
    Su, Liang
    Yu, Shunying
    Li, Chunbo
    Yu, Tao
    Sun, Jinhua
    PLOS ONE, 2015, 10 (06):
  • [30] Case-control study and meta-analysis did not confirm an association between DRD2 Ser311Cys and schizophrenia in the Japanese
    Watanabe, Y.
    Nunokawa, A.
    Kaneko, N.
    Shibuya, M.
    Egawa, J.
    Fukui, N.
    Igeta, H.
    Someya, T.
    JOURNAL OF NEUROCHEMISTRY, 2012, 123 : 75 - 75